Alagille syndrome

Former Shire asset becomes Mirum’s first FDA-approved rare disease drug
MedCity News
Thu, 09/30/21 - 10:47 am
Mirum Pharmaceuticals
Livmarli
Alagille syndrome
Shire
FDA